OXFORD BIOMEDICA PLC logo

OXFORD BIOMEDICA PLC

53 Marks
PLC
First Filed:Sep 9, 1997Latest Filed:Jun 24, 2024Address:Transport Way, Oxford, OX46LT, GB

Portfolio Overview

Registered
6(11%)
Pending
1(2%)
Dead
46(87%)
Previous
1

Top Classes

Class 5
Pharmaceuticals
34(64%)
Class 1
Industrial Chemicals & Adhesives
31(58%)
Class 42
Software, IT Services & Scientific Research
17(32%)

TTAB Proceedings

Total Proceedings
5
As Plaintiff
2(40%)
As Defendant
3(60%)

Top Firms

DYKEMA GOSSETT PLLC(Jul 2008)
10
Earth IpCo LLC(Apr 2022)
9
Muncy, Geissler, Olds & Lowe...(Jun 2024)
5
LACKENBACH SIEGEL LLP(Feb 2009)
3
Haynes and Boone, LLP(Jun 2007)
3

Trademark Activity Timeline(1997 – 2025)

Trademark Portfolio

54 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
OXB
OXB
Service Mark
Word
REGISTERED
Owner:
Serial:98615252
Filed:Jun 24, 2024
Classes:40, 42
Registration:8055616
Registered:Dec 9, 2025
Goods & Services
Custom and contract manufacture of products relating to biotechnology, namely, gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products, viral and non-viral vectors, and vaccines; Biotechnology research and laboratory analytic and diagnostic services in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; design of biotechnology manufacturing facilities; quality control and validation services in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems; product, viral vector and analytic assay development for others; laboratory services for biomanufacturing; research and development services for bio-manufacturing; genetic engineering laboratories and biochemistry laboratories; scientific and technological services and research in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; industrial analysis services in the field of biotechnology; provision of information relating to scientific research; providing scientific information in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; research and scientific analysis relating to drug discovery and development for others; scientific research and technology advisory services; scientific research and technology consultancy; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; management of scientific research projects; advisory services relating to scientific and clinical research; biological research; providing clinical and medical research information in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; clinical research in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; Scientific research in the nature of conducting clinical trials for others; bio-manufacturing development services
OXB
OXB
Service Mark
Combined
REGISTERED
Owner:
Serial:98606322
Filed:Jun 18, 2024
Classes:40, 42
Registration:7855236
Registered:Jul 8, 2025
Goods & Services
Custom and contract manufacture of products relating to biotechnology, namely, gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products, viral and non-viral vectors, and vaccines; Biotechnology research and laboratory analytic and diagnostic services in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; design of biotechnology manufacturing facilities; quality control and validation services in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems; product, viral vector and analytic assay development for others; laboratory services for biomanufacturing; research and development services for bio-manufacturing; genetic engineering laboratories and biochemistry laboratories; scientific and technological services and research in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; industrial analysis services in the field of biotechnology; provision of information relating to scientific research; providing scientific information in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; research and scientific analysis relating to drug discovery and development for others; scientific research and technology advisory services; scientific research and technology consultancy; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; management of scientific research projects; advisory services relating to scientific and clinical research; biological research; providing clinical and medical research information in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; clinical research in the field of nanotechnology, gene therapy, vector-based delivery systems and viral vector manufacturing; Scientific research in the nature of conducting clinical trials for others; bio-manufacturing development services
OXFORD BIOMEDICA
OXFORD BIOMEDICA
Service Mark
Word
REGISTERED
Owner:
Serial:79411188
Filed:Jun 18, 2024
Classes:40
Registration:7989064
Registered:Oct 21, 2025
Goods & Services
Custom manufacture of products relating to biotechnology; custom manufacture of gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products; custom manufacturing services for biotechnological products; custom manufacturing services for viral and non-viral vectors; custom manufacture of vaccines.; "OXFORD"
TETRAVECTA
TETRAVECTA
Service Mark
Word
PENDING
Owner:
Serial:98432248
Filed:Mar 4, 2024
Classes:40, 42
Goods & Services
Custom manufacture of products relating to biotechnology, namely, custom manufacture of cell and gene therapies; custom manufacture of gene and cell-based therapy products, namely, cell and gene therapies, genetically engineered viral vectors, genetically engineered retroviral vectors, genetically engineered lentiviral vectors, genetically engineered adeno-associated viral vectors, genetically engineered adenoviral vectors, and non-vector preparations in the nature of cell and gene therapies, and biopharmaceutical preparations; biotechnology contract manufacturing services, namely, contract manufacturing in the field of cell and gene therapy using biological organisms; contract manufacturing services of gene and cell-based therapy products, namely, cell and gene therapies, genetically engineered viral vectors, genetically engineered retroviral vectors, genetically engineered lentiviral vectors, genetically engineered adeno-associated viral vectors, genetically engineered adenoviral vectors, and non-vector preparations in the nature of cell and gene therapies and biopharmaceutical products, namely, cell and gene therapies; contract manufacturing services of technology for biopharmaceutical products and gene and cell-based products, namely, custom manufacture of cell and gene therapies; contract manufacturing services of technology for viral vectors, retroviral vectors, lentiviral vectors, adeno-associated viral vectors, adenoviral vectors, and non-vector preparations, namely, custom manufacture of cell and gene therapies; Research and laboratory analytic and diagnostic services, namely, scientific research, biochemical research, research laboratory analysis services in the field of gene therapy and biochemistry; product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems; product, viral vector product and analytic assay product development for others; laboratory services, namely, scientific laboratory services and biological research laboratory services; research and development services, namely, gene therapy research; genetic engineering laboratories, namely, scientific research in the field of genetic engineering provided in genetic engineering laboratories and biochemistry laboratories providing research and development in the field of biochemistry; scientific and technological services and research, namely, scientific research, analysis, testing in the fields of gene therapy and biochemistry; industrial analysis services, namely, providing analysis services with respect to gene-therapy based product manufacturing for industrial purposes; provision of information relating to scientific research; provision of scientific information in the fields of gene therapy and biochemistry; product research and scientific analysis of cell and gene therapies relating to drug discovery and product development for others; scientific advisory services relating to biochemistry; scientific consultancy services relating to biochemistry; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals
OXB SOLUTIONS
OXB SOLUTIONS
Trademark
Word
REGISTERED
Owner:
Serial:97361213
Filed:Apr 13, 2022
Classes:5, 40, 42, +2
Registration:7683507
Registered:Feb 11, 2025
Goods & Services
Custom manufacture of products relating to biotechnology; manufacture of gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products; manufacture of biotechnology products; manufacture of viral and non-viral vectors; manufacture of vaccines; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases, vaccines; pharmaceutical substances and preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by bacteria, viruses and parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; gene therapy products, namely, nanoparticles, viral vectors, retroviral vectors, lentiviral vectors and non-viral vectors for the delivery of genes to cells, all for medical purposes; vaccine manufacturing preparations; viral vaccines, namely, viral vector, retroviral vector, lentiviral vector and non-viral vector preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by bacteria, viruses and parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; biochemical and chemical products for use in medical science, namely, viral vectors; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; pharmaceutical and biochemical preparations for contraceptive purposes; Preparation and review of reports for regulatory approval of pharmaceuticals and bioceuticals; licensing of intellectual property; regulatory compliance consulting in the field of chemistry manufacturing and controls (CMC) activities; Medical diagnostic testing; information relating to pharmaceuticals, bioceuticals and advanced therapy medicinal products; providing medical information to medical professionals in the form of reports in the field of biotechnology, gene therapy and cell therapy; consultancy, advice and information in the field of clinical trials, healthcare, pharmaceuticals and advanced therapy medicinal products; medical advisory services relating to vaccination regimes; medical advisory services relating to the treatment, relief and/or prevention of cancer, infectious diseases, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases, reproductive system disorders, and pharmaceutical and biochemical preparations for contraceptive purposes, in humans and animals; "SOLUTIONS"; Scientific research and development services in the field of biochemistry and genetic engineering; biochemistry engineering; genetic engineering; design of manufacturing facilities; quality control for others; scientific and technological services, namely, testing and validation services in the fields of gene and cell therapy and biotechnology; product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems; medical and scientific laboratory services; scientific and technological services, namely, scientific research, development and analysis in the fields of gene and cell therapy and biotechnology; industrial analysis services, namely, analysis of viral vectors and gene therapy products to assure compliance with medical and pharmaceutical industry standards; provision of scientific information in the field of biotechnology, gene therapy and cell therapy; research and scientific analysis relating to drug discovery and development for others; scientific research in the nature of conducting clinical trials for others; manufacture of viral vectors, gene therapy and cell therapy products; product and manufacturing process development in the fields of biotechnology, gene therapy and cell therapy
OXFORD BIOMEDICA SOLUTIONS
REGISTERED
Owner:
Serial:97361222
Filed:Apr 13, 2022
Classes:5, 40, 42, +2
Registration:7683508
Registered:Feb 11, 2025
Goods & Services
Custom manufacture of products relating to biotechnology; manufacture of gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products; manufacture of biotechnology products; manufacture of viral and non-viral vectors; manufacture of vaccines; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases, vaccines; pharmaceutical substances and preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by bacteria, viruses and parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; gene therapy products, namely, nanoparticles, viral vectors, retroviral vectors, lentiviral vectors and non-viral vectors for the delivery of genes to cells, all for medical purposes; vaccine manufacturing preparations; viral vaccines, namely, viral vector, retroviral vector, lentiviral vector and non-viral vector preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by bacteria, viruses and parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; biochemical and chemical products for use in medical science, namely, viral vectors; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; pharmaceutical and biochemical preparations for contraceptive purposes; Preparation and review of reports for regulatory approval of pharmaceuticals and bioceuticals; licensing of intellectual property; regulatory compliance consulting in the field of chemistry manufacturing and controls (CMC) activities; Medical diagnostic testing; information relating to pharmaceuticals, bioceuticals and advanced therapy medicinal products; providing medical information to medical professionals in the form of reports in the field of biotechnology, gene therapy and cell therapy; consultancy, advice and information in the field of clinical trials, healthcare, pharmaceuticals and advanced therapy medicinal products; medical advisory services relating to vaccination regimes; medical advisory services relating to the treatment, relief and/or prevention of cancer, infectious diseases, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases, reproductive system disorders, and pharmaceutical and biochemical preparations for contraceptive purposes, in humans and animals; "OXFORD" AND "SOLUTIONS"; Scientific research and development services in the field of biochemistry and genetic engineering; biochemistry engineering; genetic engineering; design of manufacturing facilities; quality control for others; scientific and technological services, namely, testing and validation services in the fields of gene and cell therapy and biotechnology; product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems; medical and scientific laboratory services; scientific and technological services, namely, scientific research, development and analysis in the fields of gene and cell therapy and biotechnology; industrial analysis services, namely, analysis of viral vectors and gene therapy products to assure compliance with medical and pharmaceutical industry standards; provision of scientific information in the field of biotechnology, gene therapy and cell therapy; research and scientific analysis relating to drug discovery and development for others; scientific research in the nature of conducting clinical trials for others; manufacture of viral vectors, gene therapy and cell therapy products; product and manufacturing process development in the fields of biotechnology, gene therapy and cell therapy
USHSTAT
USHSTAT
Trademark
Word
CANCELLED
Owner:
Serial:87807055
Filed:Feb 22, 2018
Classes:1, 5, 10, +1
Registration:5700940
Registered:Mar 19, 2019
Goods & Services
Enzymes for scientific and research purposes; chemicals for use in industry and science, namely, chemicals for in-vitro use and analysis in laboratories; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, nucleic acid sequences and chemical reagents for other than medical and veterinary purposes, namely, cloning vehicles and vectors and recombinant deoxyribonucleic acid variations thereof, all for in-vitro and in-vivo use in laboratory or medical research; chemical reagents for use in medical science | Gene therapy products, namely, genetically engineered tissues for transplant purposes and gene delivery pharmaceuticals; vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic/angiogenic molecules, all for medical purposes; nucleic acid sequences and chemical reagents for medical purposes, namely, retroviral vectors and retroviral vector manufacturing preparations; pharmaceutical and biochemical preparations for the treatment of diseases of the eye and Usher's disease; biochemical preparations for medical purposes, namely, gene based therapeutics for the treatment of a juvenile degenerative retinal disease; pre-filled vials containing gene therapy pharmaceutical preparations | Medical instruments and apparatus for the administration of antibody-based therapy, gene therapy and prophylaxis preparations and substances; syringes and injectors for medical purposes | Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new products for others in the field of biotechnology; advisory services relating to research and development of gene therapy products
LENTIVECTOR
LENTIVECTOR
Trademark
Word
REGISTERED
Owner:
Serial:86538703
Filed:Feb 18, 2015
Classes:1, 5, 42
Registration:4967276
Registered:May 31, 2016
Goods & Services
[ Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing retroviral vector preparations and/or nucleic acid suitable for gene therapy; retroviral vector preparations for use in gene therapy; pharmaceutical preparations containing a retroviral vector delivering genes to cells for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS, neurodegenerative diseases, diseases of the eye, leukemia and bodily conditions associated with impaired immunosystems ]; [ Chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations ]; Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new products in the field of biotechnology
MONUDIN
MONUDIN
Trademark
Word
CANCELLED
Owner:
Serial:85693119
Filed:Aug 1, 2012
Classes:1
Registration:4591003
Registered:Aug 26, 2014
PROCASTAT
PROCASTAT
Trademark
Word
CANCELLED
Owner:
Serial:85329158
Filed:May 24, 2011
Classes:5
Registration:4266518
Registered:Jan 1, 2013
PROCASTAT
PROCASTAT
Trademark
Word
ABANDONED
Owner:
Serial:85329128
Filed:May 24, 2011
Classes:5
IMMSTAT
IMMSTAT
Trademark
Word
CANCELLED
Owner:
Serial:85285143
Filed:Apr 4, 2011
Classes:5
Registration:4259976
Registered:Dec 18, 2012
ENCORSTAT
ENCORSTAT
Trademark
Word
CANCELLED
Owner:
Serial:77767425
Filed:Jun 24, 2009
Classes:1
Registration:4200422
Registered:Sep 4, 2012
USHSTAT
USHSTAT
Trademark
Word
CANCELLED
Owner:
Serial:77767342
Filed:Jun 24, 2009
Classes:1
Registration:4014320
Registered:Aug 23, 2011
OXFORD BIOMEDICA
OXFORD BIOMEDICA
Trademark
Word
CANCELLED
Owner:
Serial:77673768
Filed:Feb 19, 2009
Classes:1
Registration:3968293
Registered:May 31, 2011
Goods & Services
"OXFORD"
HEPXIA
HEPXIA
Trademark
Word
ABANDONED
Owner:
Serial:77535012
Filed:Jul 30, 2008
Classes:1
STARGEN
STARGEN
Trademark
Word
ABANDONED
Owner:
Serial:77252613
Filed:Aug 10, 2007
Classes:5
BIOMEDICA
BIOMEDICA
Trademark
Word
CANCELLED
Owner:
Serial:79045357
Filed:Jun 25, 2007
Classes:1
Registration:3643630
Registered:Jun 23, 2009
TRIST
TRIST
Trademark
Word
CANCELLED
Owner:
Serial:79043527
Filed:Jun 14, 2007
Classes:1
Registration:3587260
Registered:Mar 10, 2009
CHANEX
CHANEX
Trademark
Word
CANCELLED
Owner:
Serial:77116990
Filed:Feb 27, 2007
Classes:5
Registration:3408109
Registered:Apr 8, 2008
PROSAVIN
PROSAVIN
Trademark
Word
CANCELLED
Owner:
Serial:79035964
Filed:Jan 22, 2007
Classes:5
Registration:3414764
Registered:Apr 22, 2008
HI-8
HI-8
Trademark
Word
CANCELLED
Owner:
Serial:79031759
Filed:Sep 26, 2006
Classes:5
Registration:3385687
Registered:Feb 19, 2008
LENTIVECTOR
LENTIVECTOR
Trademark
Word
CANCELLED
Owner:
Serial:78921416
Filed:Jun 30, 2006
Classes:1, 5, 40, +2
Registration:3488718
Registered:Aug 19, 2008
Goods & Services
Class 001: Chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations; Class 005: Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acid for a system delivering genes to non-dividing cells for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, leukemia and bodily conditions associated with impaired immunosystem; Class 040: Material treatment, namely, chemical synthesis for others featuring the development of a process to manufacture ingredients or finished biochemical products for applications in biotechnology; Class 042: Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new products in the field of biotechnology; Class 044: Medical services
REPOXYGEN
REPOXYGEN
Trademark
Word
CANCELLED
Owner:
Serial:78430797
Filed:Jun 7, 2004
Classes:1
Registration:3182505
Registered:Dec 12, 2006
INNUREX
INNUREX
Trademark
Word
CANCELLED
Owner:
Serial:78378648
Filed:Mar 4, 2004
Classes:1
Registration:3431115
Registered:May 20, 2008
GLIOSTAT
GLIOSTAT
Trademark
Word
CANCELLED
Owner:
Serial:78376905
Filed:Mar 2, 2004
Classes:10
Registration:3094921
Registered:May 23, 2006
BETOVAC
BETOVAC
Trademark
Word
CANCELLED
Owner:
Serial:79003755
Filed:Feb 24, 2004
Classes:5, 10
Registration:3004590
Registered:Oct 4, 2005
Goods & Services
Class 005: Clinical medical reagents for use in gene therapy; pharmaceutical preparations, namely, vaccines, for use in gene therapy; therapeutic compositions containing lipsome reagents or nucleic acid suitable for gene therapy; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, HIV and aids related infections and bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation, diseases of the nervous system, cardiac disorders, inflammatory and auto-immune diseases; pharmaceutical preparations, namely, vaccines, for use in the treatment of cancer, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation, diseases of the nervous system, cardiac disorders, inflammatory and auto-immune diseases; enzymes and enzyme preparations for medical purposes; retroviral vector and retroviral vector manufacturing preparations; chemotherapeutics for medical use; Class 010: Instruments and apparatus for the administration of gene therapy products, namely, Pre-filled vials, syringes and injectors, catheters, and tubes; surgical and medical apparatus and instruments, namely, scalpels, knives, forceps and surgical clips
GLIOSTAT
GLIOSTAT
Trademark
Word
CANCELLED
Owner:
Serial:78372913
Filed:Feb 24, 2004
Classes:1
Registration:3329030
Registered:Nov 6, 2007
IMMSTAT
IMMSTAT
Trademark
Word
CANCELLED
Owner:
Serial:78372907
Filed:Feb 24, 2004
Classes:5
Registration:2951598
Registered:May 17, 2005
PROCASTAT
PROCASTAT
Trademark
Word
CANCELLED
Owner:
Serial:79003754
Filed:Feb 24, 2004
Classes:5, 10
Registration:3029338
Registered:Dec 13, 2005
Goods & Services
Class 005: Clinical medical reagents for use in gene therapy; pharmaceutical preparations, namely, vaccines for use in gene therapy; therapeutic compositions containing liposome reagents or nucleic acid suitable for gene therapy for use in the treatment of cancer and auto-immune disorders; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS-related infections and bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularization diseases of the nervous system, cardiac disorders, inflammatory and auto-immune diseases; pharmaceutical preparations and vaccines for use in the treatment of cancer, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularization, diseases of the nervous system, cardiac disorders, inflammatory and auto-immune diseases; enzymes and enzymatic preparations for medical use in the treatment of bacterial infections; retroviral vector preparations for medical use in the treatment of cancer; and chemotherapeutics for medical use; Class 010: Instruments and apparatus for the administration of gene therapy products, namely, vials, syringes, injectors, catheters and tubes; and surgical and medical apparatus and instruments, namely, scalpels, knives, forceps and surgical clips
TROVAX-VET
TROVAX-VET
Trademark
Word
CANCELLED
Owner:
Serial:78263331
Filed:Jun 17, 2003
Classes:5
Registration:3105831
Registered:Jun 20, 2006
MONUDIN
MONUDIN
Trademark
Word
CANCELLED
Owner:
Serial:78262176
Filed:Jun 13, 2003
Classes:1
Registration:3214651
Registered:Mar 6, 2007
REQUINATE
REQUINATE
Trademark
Word
CANCELLED
Owner:
Serial:78262195
Filed:Jun 13, 2003
Classes:1
Registration:3214652
Registered:Mar 6, 2007
RETINOSTAT
RETINOSTAT
Trademark
Word
CANCELLED
Owner:
Serial:78260879
Filed:Jun 11, 2003
Classes:1
Registration:3372819
Registered:Jan 22, 2008
PLENTI
PLENTI
Trademark
Word
CANCELLED
Owner:
Serial:78196878
Filed:Dec 20, 2002
Classes:1, 5, 42, +1
Registration:2963058
Registered:Jun 21, 2005
Goods & Services
Class 001: chemicals for use in the manufacture of viruses, vectors, pharmaceuticals and retroviral vector preparations for use in industry, science and medical science; enzymes and chemical products for in vitro use in laboratories and for analysis in and development of gene delivery technology; micro organisms, cell cultures, plasmids and cultures of micro organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid and variations thereof, all for in vivo or ex vivo use in gene delivery technology and cloning technology; Class 005: clinical medical reagents for use in gene therapy, pharmaceutical preparations for use in gene therapy,enzymes and enzyme preparations for medical purpose, for use in gene delivery and cloning technology, retroviral vector and retroviral vector manufacturing preparations for use in gene delivery and cloning technology; Class 042: scientific and medical research and development, and product development; genetic engineering services, biotechnology services, namely research and development of new products for others in the field of gene technology and gene therapy; Class 044: Medical Services
PONY
PONY
Trademark
Word
CANCELLED
Owner:
Serial:78196893
Filed:Dec 20, 2002
Classes:1, 5, 42, +1
Registration:2886280
Registered:Sep 21, 2004
Goods & Services
Class 001: chemicals for use in the manufacture of viruses, vectors, pharmaceuticals and retroviral vector preparations for use in industry, science and medical science; enzymes and chemical products for in vitro use in laboratories and for analysis in and development of gene delivery technology; micro organisms, cell cultures, plasmids and cultures of micro organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid and variations thereof, all for in vivo or ex vivo use in gene delivery technology and cloning technology, none of the aforesaid goods relating to the treatment of equidae; Class 005: clinical medical reagents for use in gene therapy, pharmaceutical preparations for use in gene therapy, enzymes and enzyme preparations for medical purpose, for use in gene delivery and cloning technology, retroviral vector and retroviral vector manufacturing preparations for use in gene delivery and cloning technology, none of the aforesaid goods relating to the treatment of equidae; Class 042: scientific and medical research and development, and product development; genetic engineering services, biotechnology services, namely research and development of new products for others in the field of gene technology and gene therapy, none of the aforesaid services relating to the treatment of equidae; Class 044: medical services
PLENTIVECTOR
PLENTIVECTOR
Trademark
Word
CANCELLED
Owner:
Serial:76396372
Filed:Apr 16, 2002
Classes:1, 5, 42, +1
Registration:2993591
Registered:Sep 13, 2005
Goods & Services
Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acid for a system delivering genes to non-dividing cells for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, leukemia and bodily conditions associated with impaired immunosystem; Chemical compositions containing nucleic acids for use in the manufacture of pharmaceutical and retroviral vector preparations; medical services; Scientific and medical product research and development, genetic engineering services for scientific and medical research use, biotechnology services, namely, research and development of new products in the field of biotechnology, genetic engineering services for scientific and medical research use
ECOPACK
ECOPACK
Trademark
Word
CANCELLED
Owner:
Serial:78033527
Filed:Nov 2, 2000
Classes:1, 5, 42
Registration:2656573
Registered:Dec 3, 2002
Goods & Services
Class 001: Chemical and biochemical products for use in gene therapy; reagents for use in scientific and medical research concerning gene therapy, namely, enzymes and enzymes for use in the manufacture of gene therapy products, chemical compositions containing nucleic acids for use in the manufacture of retroviral vector preparations; Class 005: Gene therapy products, namely, clinical or medical reagents for use in gene therapy; retroviral vector preparations for clinical or medical laboratory use; chemical and biochemical products for use in medical science, namely, diagnostic reagents for clinical or medical laboratory use; chemical and biochemical products for in vitro use in laboratories; reagents, namely, micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for clinical or medical laboratory use, namely, in vivo use; Class 042: Scientific and medical research and development, medical services; genetic engineering services for others; biotechnology research and development services for others
LENTISCREEN
LENTISCREEN
Trademark
Word
CANCELLED
Owner:
Serial:78033533
Filed:Nov 2, 2000
Classes:1, 5, 42
Registration:3115887
Registered:Jul 18, 2006
Goods & Services
Class 001: CHEMICAL AND BIOCHEMICAL PRODUCTS FOR USE IN THE GENE DELIVERY TECHNOLOGY, ENZYMES AND CHEMICALS FOR IN VITRO USE IN LABORATORIES AND FOR ANALYSIS FOR USE IN THE GENE DELIVERY TECHNOLOGY, MICRO-ORGANISMS, DEOXYRIBONUCLEIC ACID SEQUENCES, CLONING VEHICLES AND RECOMBINANT DEOXYRIBONUCLEIC ACID AND VARIATIONS THEREOF, ALL FOR IN VIVO USE IN GENE DELIVERY TECHNOLOGY, AND CATALYSTS FOR GENE DELIVERY TECHNOLOGY; Class 005: GENE THERAPY AND PROPHYLAXIS PRODUCTS, NAMELY, GENE DELIVERY PRODUCTS; ENZYMES AND ENZYME PREPARATIONS FOR USE IN THE MEDICAL INDUSTRY, VECTORS, RETROVIRAL VECTORS AND VECTOR AND RETROVIRAL VECTOR MANUFACTURING PREPARATIONS, ALL FOR USE IN GENE DELIVERY TECHNOLOGY, PRODUCTS FOR USE IN VECTOR PRODUCTION TECHNOLOGIES, NEUROGENOMICS PRODUCTS; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACIDS FOR ASSISTANCE IN DELIVERING GENE THERAPY AND PROPHYLAXIS, NAMELY, GENE DELIVERY SYSTEMS; VACCINES FOR USE IN THE TREATMENT OF DISEASES OF THE BRAIN AND NERVOUS SYSTEM AND MOTOR NEURONE DISEASES, GENE THERAPY AND PROPHYLAXIS AND CHEMICALS AND BIOCHEMICALS FOR USE IN THE MEDICAL INDUSTRY; Class 042: SCIENTIFIC AND MEDICAL RESEARCH AND DEVELOPMENT, GENETIC ENGINEERING SERVICES, BIOTECHNOLOGY SERVICES, NAMELY, BIOTECHNOLOGY RESEARCH IN THE DEVELOPMENT OF THERAPEUTIC PRODUCTS AND VACCINES; MEDICAL RESEARCH AND DEVELOPMENT IN THE FIELD OF VECTOR PRODUCTION TECHNOLOGIES
LENTITRAP
LENTITRAP
Trademark
Word
CANCELLED
Owner:
Serial:78033538
Filed:Nov 2, 2000
Classes:1, 5, 42
Registration:2677995
Registered:Jan 21, 2003
Goods & Services
Class 001: CHEMICAL AND BIOCHEMICAL PRODUCTS FOR USE IN THE GENE DELIVERY TECHNOLOGY, ENZYMES AND CHEMICALS FOR IN VITRO USE IN LABORATORIES AND FOR ANALYSIS FOR USE IN THE GENE DELIVERY TECHNOLOGY, MICRO-ORGANISMS, DEOXYRIBONUCLEIC ACID SEQUENCES, CLONING VEHICLES AND RECOMBINANT DEOXYRIBONUCLEIC ACID AND VARIATIONS THEREOF, ALL FOR IN VIVO USE IN GENE DELIVERY TECHNOLOGY AND CATALYSTS FOR GENE DELIVERY TECHNOLOGY; Class 005: GENE THERAPY AND PROPHYLAXIS PRODUCTS, NAMELY, GENE DELIVERY PRODUCTS; ENZYMES AND ENZYME PREPARATIONS FOR USE IN THE MEDICAL INDUSTRY, VECTORS, RETROVIRAL VECTORS AND VECTOR AND RETROVIRAL VECTOR MANUFACTURING PREPARATIONS, ALL FOR USE IN GENE DELIVERY TECHNOLOGY, PRODUCTS FOR USE IN VECTOR PRODUCTION TECHNOLOGIES, NEUROGENOMICS PRODUCTS; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACIDS FOR ASSISTANCE IN DELIVERING GENE THERAPY AND PROPHYLAXIS, NAMELY, GENE DELIVERY SYSTEMS; VACCINES FOR USE IN THE TREATMENT OF DISEASES OF THE BRAIN AND NERVOUS SYSTEM AND MOTOR NEURONE DISEASES, GENE THERAPY AND PROPHYLAXIS AND CHEMICALS AND BIOCHEMICALS FOR USE IN THE MEDICAL INDUSTRY; Class 042: SCIENTIFIC AND MEDICAL RESEARCH AND DEVELOPMENT, GENETIC ENGINEERING SERVICES, BIOTECHNOLOGY SERVICES, NAMELY, BIOTECHNOLOGY RESEARCH IN THE DEVELOPMENT OF THERAPEUTIC PRODUCTS AND VACCINES; MEDICAL RESEARCH AND DEVELOPMENT IN THE FIELD OF VECTOR PRODUCTION TECHNOLOGIES
SMARTOMICS
SMARTOMICS
Trademark
Word
CANCELLED
Owner:
Serial:78033541
Filed:Nov 2, 2000
Classes:1, 5, 42
Registration:2719355
Registered:May 27, 2003
Goods & Services
Class 001: CHEMICAL AND BIOCHEMICAL PRODUCTS FOR USE IN THE GENE DELIVERY TECHNOLOGY, ENZYMES AND CHEMICALS FOR IN VITRO USE IN LABORATORIES AND FOR ANALYSIS FOR USE IN THE GENE DELIVERY TECHNOLOGY, MICRO-ORGANISMS, DEOXYRIBONUCLEIC ACID SEQUENCES, CLONING VEHICLES AND RECOMBINANT DEOXYRIBONUCLEIC ACID AND VARIATIONS THEREOF, ALL FOR IN VIVO USE IN GENE DELIVERY TECHNOLOGY AND CATALYSTS FOR GENE DELIVERY TECHNOLOGY; Class 005: GENE THERAPY AND PROPHYLAXIS PRODUCTS, NAMELY, GENE DELIVERY PRODUCTS; ENZYMES AND ENZYME PREPARATIONS FOR USE IN THE MEDICAL INDUSTRY, VECTORS, RETROVIRAL VECTORS, VECTOR AND RETROVIRAL VECTOR MANUFACTURING PREPARATIONS, ALL FOR USE IN GENE DELIVERY TECHNOLOGY, PRODUCTS FOR USE IN VECTOR PRODUCTION TECHNOLOGIES, NEUROGENOMICS PRODUCTS; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACIDS FOR ASSISTANCE IN DELIVERING GENE THERAPY AND PROPHYLAXIS, NAMELY, GENE DELIVERY SYSTEMS; VACCINES FOR USE IN THE TREATMENT OF DISEASES OF THE BRAIN AND NERVOUS SYSTEM AND MOTOR NEURONE DISEASES, GENE THERAPY AND PROPHYLAXIS AND CHEMICALS AND BIOCHEMICALS FOR USE IN THE MEDICAL INDUSTRY; Class 042: SCIENTIFIC AND MEDICAL RESEARCH AND DEVELOPMENT, GENETIC ENGINEERING SERVICES, BIOTECHNOLOGY SERVICES, NAMELY, BIOTECHNOLOGY RESEARCH IN THE DEVELOPMENT OF THERAPEUTIC PRODUCTS AND VACCINES; MEDICAL RESEARCH AND DEVELOPMENT IN THE FIELD OF VECTOR PRODUCTION TECHNOLOGIES
FUSITAB
FUSITAB
Trademark
Word
CANCELLED
Owner:
Serial:78030862
Filed:Oct 16, 2000
Classes:5, 10, 42
Registration:2747063
Registered:Aug 5, 2003
Goods & Services
Class 005: Gene therapy and prophylaxis products, namely, clinical, medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents/nucleic acid/antibodies for gene therapy; vaccines; enzymes and enzyme preparations for medical purposes, namely, gene therapy for use in the treatment of viral and bacterial infections, cancer and bodily conditions associated with immunosystems; Class 010: instruments, apparatus surgical and medical apparatus and instruments, all for the administration of gene therapy treatment and for the administration of prophylaxis products, namely, syringes, scalpels, catheters, and tubes for the administration of gene therapy products; Class 042: Scientific and medical research and product development; medical services; genetic engineering services; biotechnology services, namely, research and development of new products in the field of biotechnology; scientific and medical research and development of new products in the field of gene therapy
75885965
75885965
Trademark
Design
CANCELLED
Owner:
Serial:75885965
Filed:Dec 30, 1999
Classes:1
Registration:2914053
Registered:Dec 28, 2004
CHANEX
CHANEX
Trademark
Word
CANCELLED
Owner:
Serial:75559264
Filed:Sep 24, 1998
Classes:5, 10
Registration:2437902
Registered:Mar 27, 2001
Goods & Services
Clinical, medical reagents for use in the gene therapy; pharmaceutical preparations for use in gene therapy; Therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acids for gene therapy; pharmaceutical preparations containing nucleic acid for use in the treatment of cancer, HIV and AIDS related infections and bodily conditions associated with impaired immunosystems; viral and bacterial diseases, cancer and cystic fibrosis, pharmaceutic preparations in the field of gene therapy, pharmaceutics preparations for the treatment of cystic fibrosis; Instruments and apparatus for the administration of gene therapy, namely, syringes, scalpels, catheters, tubes for the administration of gene therapy products; surgical and medical apparatus and instruments, namely, syringes, scalpels, catheters and tubes for medical services
HEPXIA
HEPXIA
Trademark
Word
CANCELLED
Owner:
Serial:75513721
Filed:Jul 1, 1998
Classes:1, 5, 10
Registration:2476974
Registered:Aug 14, 2001
Goods & Services
CHEMICAL COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE MANUFACTURE OF GENE THERAPY PREPARATIONS
METXIA
METXIA
Trademark
Word
CANCELLED
Owner:
Serial:75381002
Filed:Oct 28, 1997
Classes:1, 5, 10
Registration:2622533
Registered:Sep 24, 2002
Goods & Services
CLINICAL MEDICAL REAGENTS FOR USE IN GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING LIPSOME REAGENTS SUITABLE FOR GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING NUCLEIC ACID FOR GENE THERAPY; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS, CANCER, HIV AND AIDS RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS; PHARMACEUTICAL PREPARATIONS IN THE FIELD OF GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER; CHEMICAL COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS AND RETROVIRAL VECTOR PREPARATIONS; INSTRUMENTS AND APPARATUS FOR THE ADMINISTRATION OF GENE THERAPY AND GENE THERAPY PRODUCTS, NAMELY, SYRINGES, SCALPELS, CATHETERS, AND TUBES FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS
GLIOSTAT
GLIOSTAT
Trademark
Word
CANCELLED
Owner:
Serial:75355337
Filed:Sep 11, 1997
Classes:1, 5, 10
Registration:2250961
Registered:Jun 8, 1999
Goods & Services
clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing lipsome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, HIV and aids related infections and bodily conditions associated with impaired immunosystems; pharmaceutical preparations in the field of gene therapy; pharmaceutical preparations for the treatment of cancer; chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations; instruments and apparatus for the administration of gene therapy, namely, syringes, scalpels, catheters, tubes for the administration of gene therapy products; surgical and medical apparatus and instruments for the administration of gene therapy products
LENTIVECTOR
LENTIVECTOR
Trademark
Word
CANCELLED
Owner:
Serial:75355340
Filed:Sep 11, 1997
Classes:1, 5, 40, +1
Registration:2256525
Registered:Jun 29, 1999
Goods & Services
material treatment, namely, chemical synthesis for others featuring the development of a process to manufacture ingredients or finished biochemical products for applications in biotechnology; clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acid for a system delivering genes to non-dividing cells for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, leukemia and bodily conditions associated with impaired immunosystem; chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations; scientific and medical research and development, medical services; genetic engineering services, biotechnology services, namely, research and development of new products in the field of biotechnology
PROCASTAT
PROCASTAT
Trademark
Word
CANCELLED
Owner:
Serial:75355341
Filed:Sep 11, 1997
Classes:5, 10
Registration:2222448
Registered:Feb 9, 1999
Goods & Services
clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations of the treatment of prostate cancer; pharmaceutical preparations containing nucleic acid for use in the treatment of prostate cancer; instruments and apparatus for the administration of gene therapy, namely, syringes, scalpels, catheters and tubes, for medical services surgical and medical apparatus and instruments, namely, syringes, scalpels, catheters, tubes for medical services
PROSAVIN
PROSAVIN
Trademark
Word
CANCELLED
Owner:
Serial:75355338
Filed:Sep 11, 1997
Classes:5, 10
Registration:2424308
Registered:Jan 30, 2001
Goods & Services
clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations of the treatment of prostate cancer; pharmaceutical preparations containing nucluic acid for use in the treatment of prostate cancer; instruments and apparatus for the administration of gene therapy, namely, syringes, scalpels, catheters and tubes, for medical services surgical and medical apparatus and instruments, namely, syringes, scalpels, catheters, tubes for medical services
BETOVAC
BETOVAC
Trademark
Word
CANCELLED
Owner:
Serial:75354211
Filed:Sep 9, 1997
Classes:1, 5, 10
Registration:2386761
Registered:Sep 19, 2000
Goods & Services
clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing lipsome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, HIV and aids related infections and bodily conditions associated with impaired immunosystems; pharmaceutical preparations in the field of gene therapy, pharmaceutical preparations for the treatment of cancer; chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations; instruments and apparatus for the administration of gene therapy, namely, syringes, scalpels, catheters, tubes for the administration of gene therapy, except for containers for receiving of a patient's blood
CORECTOGEN
CORECTOGEN
Trademark
Word
CANCELLED
Owner:
Serial:75354210
Filed:Sep 9, 1997
Classes:1, 5, 10
Registration:2789994
Registered:Dec 9, 2003
Goods & Services
CLINICAL MEDICAL REAGENTS FOR USE IN GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING LIPSOME REAGENTS SUITABLE FOR GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING NUCLEIC ACID FOR GENE THERAPY; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS, CANCER, HIV AND AIDS RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS; PHARMACEUTICAL PREPARATIONS IN THE FIELD OF GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER; CHEMICAL COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS AND RETROVIRAL VECTOR PREPARATIONS; INSTRUMENTS AND APPARATUS FOR THE ADMINISTRATION OF GENE THERAPY, NAMELY, SYRINGES, SCALPELS, CATHETERS, TUBES FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS; SURGICAL AND MEDICAL APPARATUS AND INSTRUMENTS FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS, NAMELY, SYRINGES, SCALPELS, INJECTORS, CATHETERS, TUBES FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS
IMMSTAT
IMMSTAT
Trademark
Word
CANCELLED
Owner:
Serial:75354209
Filed:Sep 9, 1997
Classes:1, 5, 10
Registration:2291967
Registered:Nov 16, 1999
Goods & Services
clinical medical reagents for use in gene therapy pharmaceutical preparations for use in gene therapy; therapeuctic compositions containing lipsome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, HIV and aids related infections and bodily conditions associated with impaired immunosystems; pharmaceutical preparations in the field of gene therapy; pharmaceutical preparations for the treatment of cancer; chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations; instruments and apparatus for the administration of gene therapy, namely, syringes, scalpels, catheters, tubes for the administration of gene therapy products; surgical and medical apparatus and instruments for the administration of gene therapy products
MACROGEN
MACROGEN
Trademark
Word
Previous
CANCELLED
Owner:
Serial:75559263
Filed:Sep 24, 1998
Classes:1, 5, 42
Registration:2499317
Registered:Oct 23, 2001
Goods & Services
Clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acid for a system delivering genes to non-dividing cells for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, leukemia and bodily conditions associated with impaired immunosystem; chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and gene therapy preparations; chemical compositions containing nucleic acids for specific and industrial research use, enzymes for use in the manufacture of pharmaceuticals and gene therapy preparations, in vitro chemical reagents for scientific or medical research use for analysis, microorganisms, cell cultures, plasmids and cultures in microorganisms, deo-oxyribonucleic acids sequences, cloning vehicles and recombinant deo-oxyribonucleic acid variations thereof, all for in vivo use; and chemical compositions containing enzymes for use in the manufacture of pharmaceuticals and gene therapy preparation; scientific and medical research and development; medical services; genetic engineering services, biotechnology services, namely, research and development of new products in the field of biotechnology and gene therapy

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.